Adjuvant and neoadjuvant chemotherapy in NSCLC: A paradigm shift

Lung Cancer

Volumn 50, Issue SUPPL. 2, 2005, Pages S9-

  Betticher, Daniel C ^a  

^a Hopital Cantonal de Fribourg   (Switzerland)

Author keywords

Adjuvant; Chemotherapy; Neoadjuvant; Non small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; IFOSFAMIDE; MITOMYCIN; NAVELBINE; NITROSOUREA DERIVATIVE; PACLITAXEL; STEROID; UFT; VINBLASTINE; VINDESINE;

ADJUVANT CHEMOTHERAPY; BLEEDING; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG FATALITY; EMPHYSEMA; FEVER; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; META ANALYSIS; NEUTROPENIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH HEMORRHAGE; SYSTEMATIC REVIEW;

EID: 33645019593     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(05)81568-5     Document Type: Conference Paper

References (31)

1. Mountain C.F. Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
2. Pisters K.M.W., and Le Chevalier T. Adjuvant chemotherapy in completely resected non-small cell lung cancer J Clin Oncol 23 2005 3270 3278
3. Feld R., Rubenstsin L.V., and Weisenberger T.H. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies J Clin Oncol 2 1984 1352 1358
4. Immerman S.C., Vanecko R.M., and Fry W.A. Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure Ann Thorac Surg 32 1981 23 27
5. Martini N., Flehinger B.J., and Zaman M.B. Prospective study of 445 lung carcinomas with mediastinal lymph node metastases J Thorac Cardiovasc Surg 80 1980 390 399
6. Thomas P., and Rubinstein L. Cancer recurrence after resection: T1 NO non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 49 1990 242 246
7. Rolle A., GunzeL R., and Pachmann U. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: A preliminary report WorLd J Surg Oncol 3 2005 18
8. Yasumoto K., Oskai T., and Watanabe Y. Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study Ann Thorac Surg. 76 2003 194 201
9. Pantel K., Izbicki J.R., and Angstwurm M. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer Cancer Res 53 1993 1027 1031
10. Passtick B., Kubuschok B., and Izbicki J.R. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer Ann Thorac Surg 68 1999 2053 2058
11. Non-small cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials Br Med J 311 1995 899 909
12. Waller D., Peake M.D., and Stephens R.J. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg 26 2004 173 182
13. Kato H., Ichinose Y., and Ohta M. Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N EngL J Med 350 2004 1713 1721
14. Abstract 7002 Hamada C., Ohta M., and Wada H. Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small-cell lung cancer J Clin Oncol 22 2004 617s
15. Arriagada R., Bergman B., and Dunant A. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med. 350 2004 351 360
16. Hotta K., Matsuo K., and Ueoka H. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials J Clin Oncol. 22 2004 3860 3867
17. Abstract 7019 Strauss G.M., Herndon J., and Maddaus M.A. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633 J Clin Oncol 22 2004 621s
18. Winton T., Livingston R., and Johnson D. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597
19. Abstract 7013 Douillard J., Rosell R., and Delena M. (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up J Clin Oncol 23 2005 624s
20. Scagliotti G.V., Fossati R., and Torri V. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer J Natl Cancer Inst 95 2003 1453 1461
21. Rosell R., Gomez-Codina J., and Kamps C. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 1994 153 158
22. Rosell R., Gomez-Codina J., and Camps C. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial Lung Cancer 26 1999 7 14
23. Roth J.A., Fossella F., and Komaki R. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst 86 1994 673 680
24. Roth J., Atkinson E., and Fossella F. Long-term followp-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
25. Depierre A., Milleron D., and Moro-Sibilot D. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and Illa nonsmaLL-cell lung cancer J Clin Oncol 20 2002 247 253
26. Abstract 2544 Pisters K.M., Ginsberg R.J., and Giroux D.J. Bimodality lung oncology team (BLOT) trial of induction paclitaxel/carboplatin in early-stage non-small cell lung cancer: long term follow up of a phase II trial Proc Am Soc Clin Oncol 22 2003 633
27. Abstract 7012 Pisters K., Vallieres E., and Bunn P. S9900: a phase III trial of surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): preliminary results J Clin Oncol 23 2005 624s
28. Mattson K.V., Abratt R.P., and ten Velde G. Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study Ann Oncol 14 2003 116 1122
29. Abstract7l l9 Kunitoh H., Kato H., and Tsuboi M. A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II non-small cell lung cancer (NSCLC): initial report of Japan Clinical Oncology Group trial (JCOG 0204) J Clin Oncol 23 16S 2005 650s
30. Betticher D.C., Hsu Schmitz S.F., and Totsch M. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759
31. Betticher D., Hsu Schmitz S., and Roth A. Neoadjvuant therapy with docetaxel and cisplatin in patients with non-small cell lung cancer (NSCLC), stage IIIA, pN2: a large phase II study with 59 months of follow-up Lung Cancer 49 2005 S14